The effect of two dose levels of eicosapentaenoic acid (EPA) on apoptosis and cell proliferation in the colonic mucosa of patients with a history of colonic polyps.

Trial Profile

The effect of two dose levels of eicosapentaenoic acid (EPA) on apoptosis and cell proliferation in the colonic mucosa of patients with a history of colonic polyps.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 15 Nov 2008

At a glance

  • Drugs Eicosapentaenoic acid (Primary)
  • Indications Colonic polyps; Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors SLA Pharma
  • Most Recent Events

    • 15 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Oct 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
    • 16 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top